20
May

Johnson & Johnson says it’s on track to submit more than 10 new drugs for FDA approval over the next four years, and the company believes each of those contenders has the potential to bring in $1 billion in peak revenue.

…read more

Source: J&J touts a blockbuster-rich pipeline with 10 filings on the horizon

    

0 No comments